Results 31 to 40 of about 124,684 (308)

Diuretics in heart failure – rationale for use in heart failure [PDF]

open access: yes, 2017
Heart failure is an epidemic of ageing 21st century societies. Despite wide access to modern treatment strategies, many cardiovascular diseases eventually lead to its development.
Krzesiński, Paweł   +5 more
core   +1 more source

Diuretics in chronic kidney disease [PDF]

open access: yes, 2020
The issues of diuretic therapy in patients with chronic kidney disease, pharmacokinetics of diuretics, the problem of diuretic resistance, the tactics of using thiazides and loop diuretics in patients with various stages of chronic kidney disease ...
A. I. Dyadyk   +4 more
core   +2 more sources

Pharmacotherapy for Essential Hypertension: A Brief Review

open access: yesMethodist DeBakey Cardiovascular Journal, 2022
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment.
Behnam Heidari   +2 more
doaj   +1 more source

Controlled arterial hypertension and adverse event free survival rate in heart recipients

open access: yesКардиоваскулярная терапия и профилактика, 2018
Aim. To evaluate the prevalence of arterial hypertension (AH) in heart transplant recipients, and its influence on the risk of adverse events, as the efficacy and safety of antihypertension medications (AHM).Material and methods.
A. О. Shevchenko   +4 more
doaj   +1 more source

Diuretics [PDF]

open access: yesThe American Journal of the Medical Sciences, 1898
n ...
openaire   +2 more sources

Diuretics for heart failure [PDF]

open access: yes, 2016
BACKGROUND: Chronic heart failure is a major cause of morbidity and mortality world-wide. Diuretics are regarded as the first-line treatment for patients with congestive heart failure since they provide symptomatic relief.
Flather, Marcus D.   +4 more
core   +1 more source

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial

open access: yesKidney Diseases
Introduction: VERTIS CV was a placebo-controlled cardiovascular (CV) outcome trial evaluating the sodium-glucose cotransporter 2 inhibitor ertugliflozin in patients with type 2 diabetes and established atherosclerotic CV disease.
David Z.I. Cherney   +10 more
doaj   +1 more source

Diuretics for hypertension from the perspective of novel clinical guidelines and meta-analyzes

open access: yesРоссийский кардиологический журнал, 2021
A review of the efficacy and safety of diuretics in hypertension was carried out from the standpoint of current clinical guidelines. Also, updated data from metaanalyzes of the efficacy and metabolic effects of diuretic therapy were reviewed.
S. V. Nedogoda
doaj   +1 more source

Association of diuretics with falls and wrist fractures: a Mendelian randomization study

open access: yesFrontiers in Public Health
BackgroundThe association between diuretics and falls in older adult has been reported in previous studies, but discrepancy remains between the different types of diuretics.
Fei Liu   +5 more
doaj   +1 more source

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre‐Existing Renal Impairment

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy